General's Prosecutor Office inspects Russian business of Abbott

The Russian General's Prosecutor Office has issued a warning to a local firm Veropharm, one of Russia’s leading drugmakers, (which was recently acquired by the USA’s Abbott Laboratories [NYSE: ABT]; The Pharma Letter February 9) about the permissibility of compliance with any anti-Russian sanctions, reports The Pharma Letter's local correspondent.

Several weeks ago, Abbott had demanded that Veropharm stops contacts with persons included in the sanctions’ lists of the USA and the European Union, which caused criticism from the Russian government.

According to an official spokesperson of the Russian Prosecutor Office, the imposition of such requirements by Abbott to the management and workers of Veropharm may lead to their discrimination and will be a violation of the Russian legislation.